The multifunctional NS1 protein of influenza A viruses - PubMed (original) (raw)
Review
The multifunctional NS1 protein of influenza A viruses
Benjamin G Hale et al. J Gen Virol. 2008 Oct.
Abstract
The non-structural (NS1) protein of influenza A viruses is a non-essential virulence factor that has multiple accessory functions during viral infection. In recent years, the major role ascribed to NS1 has been its inhibition of host immune responses, especially the limitation of both interferon (IFN) production and the antiviral effects of IFN-induced proteins, such as dsRNA-dependent protein kinase R (PKR) and 2'5'-oligoadenylate synthetase (OAS)/RNase L. However, it is clear that NS1 also acts directly to modulate other important aspects of the virus replication cycle, including viral RNA replication, viral protein synthesis, and general host-cell physiology. Here, we review the current literature on this remarkably multifunctional viral protein. In the first part of this article, we summarize the basic biochemistry of NS1, in particular its synthesis, structure, and intracellular localization. We then discuss the various roles NS1 has in regulating viral replication mechanisms, host innate/adaptive immune responses, and cellular signalling pathways. We focus on the NS1-RNA and NS1-protein interactions that are fundamental to these processes, and highlight apparent strain-specific ways in which different NS1 proteins may act. In this regard, the contributions of certain NS1 functions to the pathogenicity of human and animal influenza A viruses are also discussed. Finally, we outline practical applications that future studies on NS1 may lead to, including the rational design and manufacture of influenza vaccines, the development of novel antiviral drugs, and the use of oncolytic influenza A viruses as potential anti-cancer agents.
Similar articles
- The influenza virus NS1 protein as a therapeutic target.
Engel DA. Engel DA. Antiviral Res. 2013 Sep;99(3):409-16. doi: 10.1016/j.antiviral.2013.06.005. Epub 2013 Jun 21. Antiviral Res. 2013. PMID: 23796981 Free PMC article. Review. - Unexpected Functional Divergence of Bat Influenza Virus NS1 Proteins.
Turkington HL, Juozapaitis M, Tsolakos N, Corrales-Aguilar E, Schwemmle M, Hale BG. Turkington HL, et al. J Virol. 2018 Feb 12;92(5):e02097-17. doi: 10.1128/JVI.02097-17. Print 2018 Mar 1. J Virol. 2018. PMID: 29237829 Free PMC article. - Influenza A Virus Virulence Depends on Two Amino Acids in the N-Terminal Domain of Its NS1 Protein To Facilitate Inhibition of the RNA-Dependent Protein Kinase PKR.
Schierhorn KL, Jolmes F, Bespalowa J, Saenger S, Peteranderl C, Dzieciolowski J, Mielke M, Budt M, Pleschka S, Herrmann A, Herold S, Wolff T. Schierhorn KL, et al. J Virol. 2017 Apr 28;91(10):e00198-17. doi: 10.1128/JVI.00198-17. Print 2017 May 15. J Virol. 2017. PMID: 28250123 Free PMC article. - Mammalian Adaptation of an Avian Influenza A Virus Involves Stepwise Changes in NS1.
Chauché C, Nogales A, Zhu H, Goldfarb D, Ahmad Shanizza AI, Gu Q, Parrish CR, Martínez-Sobrido L, Marshall JF, Murcia PR. Chauché C, et al. J Virol. 2018 Feb 12;92(5):e01875-17. doi: 10.1128/JVI.01875-17. Print 2018 Mar 1. J Virol. 2018. PMID: 29237841 Free PMC article. - Structure and Activities of the NS1 Influenza Protein and Progress in the Development of Small-Molecule Drugs.
Kim HJ, Jeong MS, Jang SB. Kim HJ, et al. Int J Mol Sci. 2021 Apr 19;22(8):4242. doi: 10.3390/ijms22084242. Int J Mol Sci. 2021. PMID: 33921888 Free PMC article. Review.
Cited by
- Hemagglutinin and neuraminidase of a non-pathogenic H7N7 avian influenza virus coevolved during the acquisition of intranasal pathogenicity in chickens.
Ichikawa T, Hiono T, Okamatsu M, Maruyama J, Kobayashi D, Matsuno K, Kida H, Sakoda Y. Ichikawa T, et al. Arch Virol. 2024 Sep 22;169(10):207. doi: 10.1007/s00705-024-06118-z. Arch Virol. 2024. PMID: 39307848 - Sequential immunization with chimeric hemagglutinin ΔNS1 attenuated influenza vaccines induces broad humoral and cellular immunity.
Rathnasinghe R, Chang LA, Pearl R, Jangra S, Aspelund A, Hoag A, Yildiz S, Mena I, Sun W, Loganathan M, Crossland NA, Gertje HP, Tseng AE, Aslam S, Albrecht RA, Palese P, Krammer F, Schotsaert M, Muster T, García-Sastre A. Rathnasinghe R, et al. NPJ Vaccines. 2024 Sep 16;9(1):169. doi: 10.1038/s41541-024-00952-7. NPJ Vaccines. 2024. PMID: 39300090 Free PMC article. - Paramyxovirus matrix proteins modulate host cell translation via exon-junction complex interactions in the cytoplasm.
Hung CT, Haas GD, Watkinson RE, Chiu HP, Kowdle S, Stevens CS, Park A, Wohlschlegel JA, Thibault PA, Lee B. Hung CT, et al. bioRxiv [Preprint]. 2024 Sep 7:2024.09.05.611502. doi: 10.1101/2024.09.05.611502. bioRxiv. 2024. PMID: 39282406 Free PMC article. Preprint. - Unlocking influenza B: exploring molecular biology and reverse genetics for epidemic control and vaccine innovation.
Din GU, Wu C, Tariq Z, Hasham K, Amjad MN, Shen B, Yue L, Raza MA, Ashraf MA, Chen L, Hu Y. Din GU, et al. Virol J. 2024 Aug 23;21(1):196. doi: 10.1186/s12985-024-02433-8. Virol J. 2024. PMID: 39180083 Free PMC article. Review. - Evaluation of a novel intramuscular prime/intranasal boost vaccination strategy against influenza in the pig model.
Avanthay R, Garcia-Nicolas O, Ruggli N, Grau-Roma L, Párraga-Ros E, Summerfield A, Zimmer G. Avanthay R, et al. PLoS Pathog. 2024 Aug 8;20(8):e1012393. doi: 10.1371/journal.ppat.1012393. eCollection 2024 Aug. PLoS Pathog. 2024. PMID: 39116029 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources